July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%

The 6 largest  psychedelic compound-based research & development stocks are ranked below as to their performances so far in July:

  1. Seelos (SEEL): Up 25.8% so far in July
  2. Mind Medicine (MNMD): Up 22.1% so far in July
    • is primarily focused on the use of LSD* and MNMA*. Go here for much more extensive information on LSD and  here for much more extensive information on MNMA.
    • current market capitalization: $159M
    • current price/share: $4.36
    • current short interest: 9.2%
    • Read: MindMed Pipeline and Progress To Date 
  3. Atai (ATAI): Up 19.8% so far in July
  4. GH Research (GHRS): Up 18.5% so far in July
  5. Compass Pathways (CMPS): Up 9.8% so far in July
    • focused on the use of psilocybin* (magic mushrooms) in their research. Go here for much more extensive information on Psilocybin.
    • current market capitalization: $400M
    • current price/share: $9.09
    • current short interest: 14.3% - A high short interest signals that investors have become more bearish and may be getting ready to sell and, as such, that it may be time to liquidate a long position.
    • Read: This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock
  6. Incannex Healthcare (IXHL): Down 1.6% so far in July

*Read 10 Psychedelic Substances And The 36 Companies Researching Them for a description of each of the psychedelic-based compounds mentioned in this article.


The munKNEE Psychedelic Drug Stocks Index was Up 1.9% this week and is Up 15.7% so far in July.

If you are interested in this category, consider the  AdvisorShares Psychedelic ETF (PSIL) which consists of 23 such stocks - but keep in mind that the vast majority have market capitalizations of $50M or less (i.e. are nano-caps). It was DOWN 1.5% this week but remains Up 6.5% so far in July.

More By This Author:

These 9 "Penny" AI Stocks Are Up 43%, On Average, In Just 3 Months
July Summary: Upward Trend In Conservative "Cannabis" Stocks Continues
Tilray Brand Stock Jumps 28% With Release Of Its Q4 Financials

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.